Search results
Results From The WOW.Com Content Network
Image source: The Motley Fool. Opko Health (NASDAQ: OPK) Q3 2024 Earnings Call Nov 07, 2024, 4:30 p.m. ET. Contents: Prepared Remarks. Questions and Answers. Call ...
OPKO Health's (OPK) second-quarter results benefit from continued strength in its Pharmaceuticals segment. Skip to main content. 24/7 Help. For premium support please call: 800-290-4726 more ...
OPKO Health, Inc. (NASDAQ:OPK) insiders have had a fantastic week as stock increased 5.1%, and they haven't stopped buying Simply Wall St October 30, 2022 at 5:04 AM
OPKO Health is a diversified healthcare company present in more than 30 countries. The company's primary businesses include [citation needed] Bioreference Laboratories, a clinical laboratory with a core genetic testing business; The 4K Test Score, a blood test for prostate cancer; Pharmaceutical development, with products such as Rayaldee
OPKO Health (OPK) closed the most recent trading day at $3.22, moving -0.92% from the previous trading session.
Disappointing Q1 results weighed on the healthcare stock. For premium support please call: 800-290-4726 more ways to reach us
For premium support please call: 800-290-4726 more ways to reach us
You are free: to share – to copy, distribute and transmit the work; to remix – to adapt the work; Under the following conditions: attribution – You must give appropriate credit, provide a link to the license, and indicate if changes were made.